Inactive Instrument

News Peptonic Medical AB Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

31/05	Peptonic Medical Secures European Patent for Treatment of Vulvodynia	MT
31/05	Peptonic Medical AB Grants Patent in Europe for Relief of Provoked Vulvodynia in Women, Product Ready for Launch	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Peptonic Medical: Peptonic announces outcome in the rights issue and the directed issue	14/06	PU
Peptonic announces outcome in the rights issue and the directed issue	14/06	AQ
Peptonic Medical provides an operational update after the first 120 days with new CEO	11/06	AQ
Last day of trading with the unit rights in Peptonic	07/06	AQ
Peptonic Medical Secures European Patent for Treatment of Vulvodynia	31/05	MT
Peptonic Medical AB granted patent in Europe for relief of provoked vulvodynia in women. Product ready for launch.	31/05	AQ
Peptonic Medical AB Grants Patent in Europe for Relief of Provoked Vulvodynia in Women, Product Ready for Launch	31/05	CI
The subscription period in Peptonic's rights issue of units starts today	28/05	AQ
Peptonic publishes prospectus in connection with rights issue of units	24/05	AQ
PEPTONIC medical : Interim report Jan-March 2024	23/05	PU
Peptonic Medical AB Announces Organizational Changes	21/05	AQ
Peptonic Medical AB Announces Organizational Changes	21/05	CI
The board of Peptonic has decided to carry out a directed issue of units consisting of shares and warrants of series TO5	19/05	AQ
PEPTONIC medical : Updated year end report Jan-Dec 2023	16/05	PU
PEPTONIC medical : Year end report Jan Dec 2023	16/05	PU
Sweden’s Peptonic Medical Names New CFO	15/05	MT
Jenni Björnulfson appointed as new CFO of Peptonic Medical	15/05	AQ
PEPTONIC medical AB Announces Chief Financial Officer Changes	15/05	CI
Warrants of series TO4 were subscribed to approximately 1.80 percent and Peptonic receives approximately SEK 0.1 million	07/05	AQ
PEPTONIC medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Peptonic Medical AB Nasdaq Stockholm

Equities

Summary

Filters